Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 26 , ISSUE 4 ( April, 2022 ) > List of Articles

Original Article

Role of ABO Blood Groups in Susceptibility and Severity of COVID-19 in the Georgian Population

Levan Ratiani, Tamar V Sanikidze, George Ormotsadze, Elene Pachkoria, Giga Sordia

Keywords : AOB blood groups, COVID-19, Rhesus factor, Severity of disease

Citation Information : Ratiani L, Sanikidze TV, Ormotsadze G, Pachkoria E, Sordia G. Role of ABO Blood Groups in Susceptibility and Severity of COVID-19 in the Georgian Population. Indian J Crit Care Med 2022; 26 (4):489-492.

DOI: 10.5005/jp-journals-10071-24169

License: CC BY-NC 4.0

Published Online: 13-05-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Aim and objective: The establishment of the potential role of the infected people's ABO blood type in the virus infectivity and aggressivity could clarify the aspects of the various susceptibility to virus and play a key role in assessing its spreading potential in the future. We studied the possible association of risk of coronavirus disease-2019 (COVID-19) infection and severe outcomes of disease with ABO blood groups and Rh factor in the Georgian population. Materials and methods: The effect of blood type on the severity of infection in COVID-19 positive patients admitted to the First University Clinic of Tbilisi State University (Tbilisi, Georgia) from December 2020 to September 2021 was analyzed retrospectively. The odds ratio (OR) criterion was used to determine the influence of the blood group on the risk of COVID-19 infection and of severe course of the disease. Results: The incidence of COVID-19 was 1.65-fold higher in the patients with blood group II(A), and average twice lower in patients with blood groups III(B) and IV(AB), compared with the ABO blood group distribution in healthy donors of the region. The percentage of patients transferring in ICU with I(O) and II(A) blood groups was enough high (42–40%), whereas in patients with III(B) and IV(AB) blood groups very low (12–6%). There were not revealed any statistically significant differences in the distribution of the patients with Rh+ and Rh− blood groups in healthy and COVID-19 infected individuals (including those transferred in the ICU). Conclusion: The link between patients’ ABO blood groups and receptivity to COVID-19 infection, progression and severity of the disease, has been detected. These results are relevant in terms of elucidating the mechanisms and risk factors of infecting and severity course of COVID-19 disease.

  1. Global tally of confirmed coronavirus cases surpasses 100 million. Available from:
  2. Sahu KK, Kumar R. Preventive and treatment strategies of COVID-19: from community to clinical trials. J Fam Med Prim Care 2020;9: 2149–2157. DOI: 10.4103/jfmpc.jfmpc 728_20.
  3. Kumar A. COVID-19: epidemiology, case fatalities and the adversaries within. Indian J Crit Care Med 2021;25(6):603–605. DOI: 10.5005/jp-journals-10071-23869.
  4. Kim Y, Latz LA, DeCarlo ChS, Lee S, Png CYM, Kibrik P, et al. Relationship between blood type and outcomes following COVID-19 infection. Semin Vasc Surg 2021;18. DOI: 10.1053/j.semvascsurg.2021.05.005.
  5. Miotto M, Di Rienzo L, Gosti G, Milanetti E, Ruocco G. Does blood type affect the COVID-19 infection pattern? PLoS One 2021;16(5):e0251535. DOI: 10.1371/journal.pone.0251535.
  6. Yanardag Acik D, Bankir M. Relationship of SARS-CoV-2 Pandemic with Blood Groups. Transfus Med Hemother 2021;48:161–167. DOI: 10.1080/1159/000515609.
  7. Cooling L. Blood groups in infection and host susceptibility. Clin Microbiol Rev 2015;28(3):801–870. DOI: 10.1128/CMR.00109-14.
  8. Anderson JL, May HT, Knight S, Bair TL, Muhlestein JB, Knowlton KU, et al. Association of sociodemographic factors and blood group type with risk of COVID-19 in a US population. JAMA Network Open 2021;4(4):e217429. DOI: 10.1001/jamanetworkopen.2021.7429.
  9. Blood type distribution by country. Available from:
  10. Nikitina EA. Inheritance of blood groups. In: Educational–methodical manual. Saint-Petersburg; 2020.
  11. Sheskin DJ. Handbook of parametric and nonparametric statistical procedures. 3rd ed. Boca Raton, London: Chapman & Hall/CRC; 2003.
  12. Chen R, Liang W, Jiang M, Guan W, Zhan C, Wang T, et al. Risk factors of fatal outcome in hospitalized subjects with coronavirus disease 2019 from a nationwide analysis in China. Chest 2020;158(1):97–105. DOI: 10.1016/j.chest.2020.04.010.
  13. Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol 2020;84:106504. DOI: 10.1016/j.intimp.2020.106504.
  14. Li R, Tian J, Yang F, Lv L, Yu J, Sun G, et al. Clinical characteristics of 225 patients with COVID-19 in a tertiary hospital near Wuhan, China. J Clin Virol 2020;127:104363. DOI: 10.1016/j.jcv.2020.104363.
  15. Ratiani L, Sanikidze T, Ormotsadze G, Vashakidze E, Shoshiashvili V, Pachkoria E, et al. The informative value of several clinical-laboratory characteristics at the time of hospitalization in terms of prognosis of disease complication with COVID-19 patients. Acta Sci Med Sci 2021;5:143–149. DOI: 10.31080/asms.2020.05.1023.
  16. Karna ST, Singh P, Revadi G, Khurana A, Shivhare A, Saigal S, et al. Frequency and impact of preadmission digestive symptoms on outcome in severe Covid-19: a prospective observational cohort study. Indian J Crit Care Med 2021;25(11):1247–1257. DOI: 10.5005/jp-journals-10071-24020.
  17. Anstee GJ. The relationship between blood groups and disease. Blood 2010;115(23):4635–4643. DOI: 10.1182/blood-2010-01-261859.
  18. Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, et al. Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility. Clin Infect Dis 2021;73(2):328–331. DOI: 10.1093/cid/ciaa1150.
  19. Frances TF. Blood groups (ABO groups). Common laboratory and diagnostic tests. 3rd ed. Lippincott; 2002. p. 15–19. DOI: 10.1093/glycob/cwn093. Epub 2008 Sep 25.
  20. Sardu C, Marfella R, Maggi P, Messina V, Cirillo P, Codella V, et al. Implications of AB0blood group in hypertensive patients with covid-19. BMC Cardiovasc Disord 2020;20(1):373. DOI: 10.1186/s12872-020-01658-z.
  21. Guillon P, Clément M, Sebille V, Rivain J-G, Chou Ch-F, Ruvoen-Clouet N, et al. Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology 2008;18(12):1085–1093. DOI: 10.1093/glycob/cwn093.
  22. Yamamoto F, Cid E, Yamamoto M, Blancher A. ABO research in the modern era of genomics. Transfus Med Rev 2012;26(2):103–118. DOI: 10.1016/j.tmrv.2011.08.002.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.